Sign in
4

Changes in Ownership

Serina Therapeutics, Inc. Filed Acc 0001301120-26-000006

Chief Scientific Officer sold 4,000 shares at an average $3.04 ($12,140)

  • Chief Scientific Officer acquired 4,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Moreadith Randall · Chief Scientific Officer

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2026-01-20 Exercise or conversion : show line 1 in the form 10b5-1 +2,000 $0.06 $120 2,000 D
2026-01-20 Sale : show line 2 in the form 10b5-1 −2,000 $3.07 $6,140 0 D
2026-01-21 Exercise or conversion : show line 3 in the form 10b5-1 +2,000 $0.06 $120 2,000 D
2026-01-21 Sale : show line 4 in the form 10b5-1 −2,000 $3.00 $6,000 0 D
Open-market sales · 4,000 sh · avg $3.04 · $12,140

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2026-01-20 Exercise or conversion : show line 5 in the form 10b5-1 Stock Option (right to buy) −2,000 330,686 D
2026-01-21 Exercise or conversion : show line 6 in the form 10b5-1 Stock Option (right to buy) −2,000 328,686 D
Loading xslF345X05/wk-form4_1769041031.xml…